Our Pipeline
| Code |
Modality |
Target |
- Discovery
- Preclinical
- Phase 1
- Phase 2
- Phase 3
|
Partner |
| Oncology |
DA-4505
|
Small molecule |
AHR |
|
|
DA-3501 (AT-211)
|
ADC |
Claudin 18.2 |
|
|
|
DA-4507
|
Small molecule |
GCN2 |
|
|
DA-4511
|
Small molecule |
SHP1 |
|
|
DA-4515
|
Small molecule |
TEAD |
|
|
DA-3101
|
Biologics |
αFAP/IL-12v |
|
|
|
DA-4531
|
Small molecule |
Undisclosed |
|
|
DA-4533
|
Small molecule |
Undisclosed |
|
|
DA-4701
|
TPD |
Undisclosed |
|
|
| Code |
Modality |
Target |
- Discovery
- Preclinical
- Phase 1
- Phase 2
- Phase 3
|
Partner |
Inflammatory/
Neurodegenerative Disease |
DA-7503
|
Small molecule |
Tau |
|
|
|
DA-7505
|
Small molecule |
Undisclosed |
|
|
DA-1301
|
CGT |
Undisclosed |
|
|
|
Inflammation Project
|
Small molecule |
Undisclosed |
|
|
Inflammation Project
|
Small molecule |
Undisclosed |
|
|
Inflammation Project
|
CGT |
Undisclosed |
|
|
|
Inflammation Project
|
CGT |
Undisclosed |
|
|
| Code |
Modality |
Target |
- Discovery
- Preclinical
- Phase 1
- Phase 2
- Phase 3
|
Partner |
Endocrine
& Others |
DA-8010
|
Small molecule |
M3 |
|
|
DA-1241
|
Small molecule |
GPR119 |
|
|
|
DA-1726
|
Peptide |
GLP1R & GCGR |
|
|
*TCR : T cell receptor, ICR : Immune checkpoint receptor